Innovating Drug Delivery Since 2006
At ActivaTek, we are pioneers in the development and commercialization of advanced transdermal drug delivery systems. Founded in 2006, we have consistently introduced cutting-edge iontophoresis technology to the medical field, improving patient care and treatment outcomes worldwide. Our mission is to provide healthcare professionals and patients with innovative, reliable, and easy-to-use solutions for drug delivery, particularly in the fields of pain management and rehabilitation.
Our journey began with the development of Trivarion®, a buffered iontophoresis technology designed to deliver drugs comfortably through the skin using a constant DC current. This technology revolutionized transdermal drug delivery by offering a precise, controlled, and comfortable treatment option for patients with acute local inflammatory conditions and those requiring local anesthesia.
Building on the success of Trivarion®, we introduced the ActivaPatch®, a wireless, self-contained iontophoresis patch that simplifies the drug delivery process. The ActivaPatch® is equipped with an intelligent microprocessor that detects skin resistance, memorizes treatment times, and provides real-time feedback to both clinicians and patients via LED indicators. This innovation allows for accurate, consistent treatment without the need for external devices or complex setups.
The ActivaDose® II is our most widely used dose controller, renowned for its accuracy and reliability. Designed for in-clinic use, it features dual channels, precise dosing capabilities, and both visual and audible alerts, making it a versatile tool for physical therapists and other medical professionals. Whether used with traditional wired electrodes or our advanced wireless systems, the ActivaDose® II ensures that every treatment is delivered with unparalleled precision.
Since our inception, ActivaTek has been at the forefront of iontophoresis innovation. We are committed to advancing the field through continuous research and development, ensuring that our products not only meet but exceed the expectations of healthcare professionals and patients alike. Our technologies offer unmatched control, flexibility, and patient comfort, making ActivaTek products the preferred choice in the medical community.
In our quest to expand our impact and reach more patients globally, ActivaTek was acquired by North Coast Medical, Inc., a leading supplier of physical rehabilitation products. This strategic partnership has allowed us to leverage North Coast Medical’s extensive resources and distribution network, bringing our best-in-class iontophoresis technology to a broader audience. Together, we continue to innovate and enhance the well-being of patients around the world.
As we move forward, ActivaTek remains dedicated to pushing the boundaries of transdermal drug delivery. Our ongoing projects include the development of new technologies and devices that will further improve the safety, efficacy, and convenience of iontophoresis treatments. We are also exploring new applications of our technology in the dermatological and cosmetic markets through our sister company, ActivaDerm, Inc.
Interested in learning more about ActivaTek and our products? Contact us today to find out how our solutions can meet your medical and rehabilitation needs.